Cough syrup row: Sample testing at designated labs now must for exporters
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
From June 1, 2023, cough syrup will be permitted to be exported only after testing and production of certificate issued by govt labs
The cough syrup contained unacceptable amounts of diethylene glycol and ethylene glycol as contaminants, as per WHO.
The Central Drugs Standard Control Organisation (CDSCO) has stopped all manufacturing activities at Noida-based Marion Biotech.
CDSCO along with UP Drug Control Administration had carried out a joint inspection of Marion's Noida facility, says health minister Mansukh Mandaviya.
Uzbekistan is the second country after Gambia to link child deaths to India made cough syrups.
The Drugs Controller General of India (DCGI) has ruled out contamination possibilities in the four products Maiden Pharma supplied to Gambia.
Notices served to the Sonipat-based company after raids by central & Haryana drug depts found 12 violations at its premises.
Maiden Pharmaceutical holds manufacturing permission for these products for export only, the government says.